REPORT INTERPRETATION

Size: px
Start display at page:

Download "REPORT INTERPRETATION"

Transcription

1

2 REPORT INTERPRETATION: Interpreting ipro Professional Continuous Glucose Monitoring (CGM) Reports and Making Therapy Adjustments TARGET AUDIENCE The audience for this section is physicians, mid-level practitioners, and CDEs who would like to gain an in-depth knowledge of ipro CGM report interpretation. READERS WILL RECEIVE GUIDANCE ON: An easy-to-follow methodology to simplify the use and interpretation of ipro CGM reports Strategies to use in making therapy adjustments Suggested ways to monitor the patient Please note that the section below is not intended to offer medical advice. INTRODUCTION Professional CGM reports provide a blueprint for a patient s current glycemic control, which can be used to recommend adjustments in the patient s therapy. The reports offer a valuable educational tool to help patients understand the impact of diet, medication, and exercise on glucose control. PRACTICE GUIDE 1

3 /27/9 (Tue) /28/9 (Wed) 4 1/29/9 (Thu) 14 7 Paired Meter Value Unpaired Meter Value Sensor Value Meal Insulin Exercise Other Time Change (From) Time Change (To) Breakfast 7-1 hr MEAL +1 hr +2 hr +3 hr Block A (3: AM - 5:59 AM) 7 3:am 4:am 5:am 8:am 7 Lunch -1 hr MEAL +1 hr +2 hr +3 hr Block B (11: PM - 6: AM) 7 11:pm 12:am 1:am 2:am 3:am 4:am 5:am 6:am 7 Dinner -1 hr MEAL +1 hr +2 hr +3 hr Block c (12: AM - 11:59 PM) 7 12:am 4:am 8:am 12:pm 4:pm 8:pm 12:am REPORT INTERPRETATION REPORT INTERPRETATIONS: What to Look for in the Reports The steps outlined in this section represent one method for organizing and evaluating a patient s glucose data. 1 It is intended as a starting point for healthcare providers and patients to review the data systematically. As you become familiar with this process, you will begin to establish your own approach to interpretation. ipro CGM provides five reports. Four are generated by the Solutions Software after a patient s data download is completed: Sensor Summary Detail, Sensor Modal Day, Sensor Modal Time and Sensor Daily Detail. The fifth report is the Patient Log Sheet, which is an important information source to be used in conjunction with the data provided by the four ipro CGM reports. See Figure 1 for a sample of the five ipro CGM reports. The Patient Log Sheet is an essential component of the ipro CGM report package because all of the patient s relevant activities and events are revealed. A precisely maintained Patient Log Sheet with reliable data regarding patient activities and events, such as exercise, meals and medication, provides crucial information for evaluating patient glucose control and guiding therapy adjustment. The Patient log sheet can either be interpreted side-by-side with the ipro CGM reports, or the data from it can be entered into Solutions Software and reflected in the printed reports. Note: Patients must understand that if they do not complete and return the log sheet, the data provided by the system is more difficult to interpret. FIGURE 1: Know your reports Sensor Summary Detail report Sensor Modal Day report Sensor Modal Time report Glucose : AM 6: AM 9: AM 12: PM 3: PM 6: PM 9: PM Quick Overview Accuracy assessment, snapshot of glucose control Identify patterns or no patterns Review glucose trend Review meals and specific time periods Review glucose trend, meal analysis and time periods for analysis Sensor Daily Detail report Patient Log Sheet report 1/26/9 (Mon) Use Clinical Judgment 1/3/9 (Fri) Use Clinical Judgment Focus on individual days and events (cause and effect/behavior) 1 One may not need to complete all steps in detail every time they perform a report interpretation. 2 PRACTICE GUIDE

4 SENSOR SUMMARY DETAIL REPORT: QUICK OVERVIEW Description: The Sensor Summary Detail report (Figure 2) provides a summary on the quality of data generated from the ipro CGM evaluation and patient s glucose excursion profile. Specifically, it provides valuable information on the patient s time in blood glucose (BG) target range compared to time high or low, the patient s BG entries, the accuracy of the sensor data, and a quantitative analysis of glucose excursions. Objectives: 1. Confirm if patient tested appropriately during the ipro evaluation period. 2. Evaluate the accuracy of sensor data generated from the evaluation. 3. Review the summary data on glucose excursion. FIGURE 2: Sensor Summary Detail report Click on Icon for Sensor Summary Detail report Sensor and Meter Information Optimal Accuracy Criteria % time in target Glucose Excursion Key steps: 1. Examine the ranges of the sensor data and the blood glucose entries to determine the appropriateness of the patient s testing. 2. Check to determine if the criteria were met in assessing optimal accuracy and if clinical judgement is required in assessing the validity of the data. 3. Evaluate the excursions area (pie chart) to analyze the duration above and below the established BG targets. For additional details on this report, please refer to the Appendix Sensor Summary Detail report. PRACTICE GUIDE 3

5 SENSOR MODAL DAY REPORT: Identify Glycemic Patterns or Lack of Patterns Description: The Sensor Modal Day report (Figure 3) identifies glycemic patterns by overlaying the sensor readings of each day into one graph. This report helps assist in pattern and trend recognition. Objectives: 1. Identify glycemic patterns or the lack thereof. For some patients, you may see a clear pattern right away, mostly for those who follow a rigid schedule. See Figure 4 for an illustration. 2. Identify glucose excursion/trends which are consistent across different days. FIGURE 3: Sensor Modal Day report Click on Icon for Sensor Modal Day report 4 Glucose - Sensor Modal Day report Overview of daily glucose patterns Hypoglycemia? Hyperglycemia? 7 3: AM 6: AM 9: AM 12: PM 3: PM 6: PM 9: PM FIGURE 4. 4 Clear patterns 4 No clear patterns Glucose - 15 Glucose : AM 6: AM 9: AM 12: PM 3: PM 6: PM 9: PM 3: AM 6: AM 9: AM 12: PM 3: PM 6: PM 9: PM Note: You will initially use the Sensor Modal Day report for the "Three Step Methodology" which is discussed later in this section. 4 PRACTICE GUIDE

6 SENSOR MODAL TIME REPORT: Identify Specific Patterns Description: The Sensor Modal Time report (Figure 5) overlays all sensor readings into graphs which display glucose patterns, pre and post meals and other specific time periods that are of interest to healthcare providers (e.g., overnight period, early morning hours). Times for meals and specific time periods for closer examination should be entered into preferences before upload. This report is based on meal markers and events entered into Solutions Software. If there is a pattern around a particular meal or timeframe, it should be readily discernable. If no meal markers are used, or no time periods of interest are identified, these reports do not populate with glucose sensor data. For this report to yield valuable information, patients must have captured details in the Patient Log Sheets. No meal period information is provided in the report if meal markers are not entered. Objectives: 1. Evaluate the effects of meals. 2. Evaluate glucose patterns during specific time periods of interest to healthcare providers. FIGURE 5: Sensor Modal Time report Click on Icon for Sensor Modal Time report 4 Breakfast 4 Lunch 4 Dinner For patterns around meals Can customize data around particular time period, such as overnight, Dawn, exercises 4 MEAL -1 hr +1 hr +2 hr +3 hr 7 Block A (3: AM - 5:59 AM) 4 MEAL -1 hr +1 hr +2 hr +3 hr 7 Block B (11: PM - 6: AM) 4 7 MEAL -1 hr +1 hr +2 hr +3 hr Block c (12: AM - 11:59 PM) Sensor Modal Time report Good for finding a pattern around meals and particular times 3:am 4:am 5:am 8:am 11:pm 12:am 1:am 2:am 3:am 4:am 5:am 6:am 12:am 4:am 8:am 12:pm 4:pm 8:pm 12:am e.g. Dawn Period e.g. Overnight Period e.g. 24 hours PRACTICE GUIDE 5

7 SENSOR DAILY DETAIL REPORT: Focus on Individual Days and Events Description: The Sensor Daily Detail report (Figure 6) provides visual details of each 24-hour period for up to seven days of individual data plots. The plots show the sensor data (daily highs and lows), meter values, and patient activity (meals, medication and exercise) during each 24-hour period. Many healthcare providers find that this is the most important report for relating meals, insulin and exercise with actual glucose results, in order to identify potential cause and effect. Event markers help to correlate patient events to glycemic excursions. Data gaps indicate that sensor glucose values were not generated during that period of time. Data gaps can be caused by several issues, including infrequent calibrations or the sensor being partially or fully dislodged. Objectives: Cause and effect analysis: Helps identify causes of glucose excursions or glucose patterns. FIGURE 6: Sensor Daily Detail report Click on Icon for Sensor Daily Detail report 4 1/26/9 (Mon) Use Clinical Judgment 4 1/27/9 (Tue) 4 1/28/9 (Wed) 4 1/29/9 (Thu) /3/9 (Fri) Use Clinical Judgment Paired Meter Value Unpaired Meter Value Sensor Value Meal Insulin Exercise Other Time Change (From) Time Change (To) Sensor Daily Detail report Generate cause and effect analysis for a particular event Track glucose and evaluate individuals days at a snapshot Monitor glucose over time Use this report in conjunction with the log sheets for detailed evaluation. This report helps identify behaviors that would not be revealed during an encounter with the patient, for example, consuming more carbohydrates than recommended. In the ipro CGM quick report preferences, some users like to print each daily report as a separate page, then record information from the Patient Log Book on these individual pages. This method might be useful to reveal a day on which the events, behaviors or diet are very different from the others. It also can allow for closer scrutiny of a particular day or event. For example, if a patient has a hypoglycemic event around 3: a.m. on one night only (with no regular pattern), the healthcare provider can review the report for the prior evening to determine if the patient consumed any notable food, whether they counted the carbohydrates in that food correctly, whether the insulin given matched well to the carbohydrates eaten, as well as the glycemic results after exercising. 6 PRACTICE GUIDE

8 KEY ITEMS TO LOOK FOR IN EACH OF THE REPORTS To analyze glucose data provided by ipro CGM, utilize a three-step methodology to allow a consistent approach. The three steps are outlined below: Step 1 Step 2 Step 3 Assess the overnight period. Assess the pre-prandial period. Assess the post-prandial period. Healthcare providers can systematically evaluate the data and identify potential cause-and-effect relationships between activities and blood glucose levels, ultimately leading to potential therapy recommendations. For each period, glucose values that are within the patient s individualized glucose target range and outside the patient s individualized target range both below (hypoglycemia) and above (hyperglycemia) can be identified. Assess tracings for hypoglycemia first, and then hyperglycemic trends and patterns. If the patient is within the range, no further assessment is required of this period. For each period, identify potential cause and effect relationships. This helps patients see the relationship between daily activities (meals, medication and activity) and their glucose levels. Consider the cause if the patient s glucose values are above or below the targeted range. These factors may include: Oral medication, insulin or injected medications. The dosage, timing and duration of medication action, storage conditions of insulin and proper use of medications taken. Meal intake and carbohydrate estimates made by patient if medication is based upon carbohydrate estimates. The type, duration and intensity of exercise and activity. The timing, quantity and composition of food, and patient carbohydrate counting accuracy, as applicable. Stress, emotion and hormones. Devices such as pump, settings of devices, and use of Bolus Wizard calculator. Use the three-step methodology when analyzing the Sensor Modal Day report, the Sensor Modal Time Period report, or the Sensor Daily Details report. Note: Excursions outside of the target glucose range need to be analyzed for causes, or what preceded the excursion. This sheds light to the changes made. PRACTICE GUIDE 7

9 STEP 1: Assess glucose pattern in the Overnight Period Glucose - 14 Definition: The "overnight period is defined as a period of fasting that occurs during a patient s sleep hours. Fasting generally means that the patient is not under the glycemic effect of dietary intake. Often, the true fasting period is usually from 24: (or midnight) to 6: a.m. in the morning, unless the patient eats late in the evening or during overnight hours. 75 3: AM 6: AM 9: AM Key Steps: Identify glucose values that are within the range and outside the range (both below and above) for the time period. Hypoglycemia or hyperglycemic determinations are based upon individualized glucose target ranges as set in the software preferences. If the patient is within the range, no further assessment is required of the period. Look for hypoglycemic excursions: Anything below the low glucose target is defined as hypoglycemia in this analysis. A low sensor glucose value overnight, may indicate the basal rate is too high. Look for hyperglycemia: Anything above the high glucose target is defined as hyperglycemia in this analysis. Assess for a preceeding hypoglycemia event and correct that prior to addressing any hyperglycemia issues. Here are the key considerations for several common patterns of events. Pattern High blood glucose at beginning of the overnight period Hypoglycemia early in overnight period Hyperglycemia later in overnight period Hypoglycemia later in overnight period Potential Considerations Late evening snack; inadequate insulin coverage or carbohydrate counting Basal rate low in preceding segment Physical or emotional stress Excessive insulin for late evening meal or bedtime snack Exercise, including sexual activity Alcohol use Basal rate too high Correction dose of insulin too high Inadequate overnight basal rate Late night snack; inadequate coverage on carbohydrate counting Preceding hypoglycemia Delayed effect of evening exercise Excessive overnight basal Delayed effect of alcohol use 8 PRACTICE GUIDE

10 STEP 2: Assess glucose pattern in the Pre-prandial Period Glucose Definition: The pre-prandial period is the period before a meal or when there is no longer active insulin from a bolus of insulin taken for the prior meal, and there are no post-meal activities (e.g., exercise) which could still have an effect on glucose levels. It is usually a period of time that occurs approximately three to five hours after the last meal. For the breakfast meal, the pre-prandial is also referred to as the fasting glucose period. People who eat frequently may not have a clearly identifiable pre-prandial period. 3: AM 6: AM 9: AM Key Steps: Evaluate the pre-prandial period first for breakfast, followed by lunch, and then for dinner. Snacks can make pre-prandial assessment challenging. Look for hypoglycemic episodes: If you find hypoglycemia, then look for a cause. Potential causes to consider include: Basal insulin too high. An overestimation of insulin required for the previous meal. Perhaps the insulin-tocarbohydrate ratio was incorrectly calculated or there was remaining active insulin from a prior bolus that was not considered, or perhaps carbohydrates were not counted correctly. Exercise or activity. Food: Review the foods and quantities eaten for previous meal. Examine the timing of the insulin given, amount given, and the type of food that was eaten. Look for hyperglycemia: Consider the same causes, such as basal, activity, and food, as above, and also consider the following: Was there an inadequate bolus from previous meal? What was the timing of the bolus for the type of meal? Was it the result of exercise, which can sometimes cause glucose to be elevated? Was this hyperglycemia event preceded by a low? Was the patient s insulin pump infusion set changed? Was the patient s insulin stored appropriately? One special consideration is the pre-prandial period for breakfast, when dawn phenomenon may occur and result in hyperglycemia prior to the breakfast meal. PRACTICE GUIDE 9

11 STEP 3: Assess glucose pattern in Post-prandial Period Glucose Definition: The "post-prandial period is defined as the period following the meal, for example, the period observed approximately two to five hours following food intake. Note: According to the American Association of Clinical Endocrinologists 2, glucose should be less than 14 at the 2-hour postprandial time period. What is normally reflected after a meal is the insulin that was given prior to the meal (meal bolus or active insulin), the previous meal s residual insulin, and any post-meal activities. 3: AM 6: AM 9: AM Key steps: Identify hypoglycemia or hyperglycemia, then look for the cause and correct it. Evaluate post-prandial periods focusing first on breakfast, then lunch, and finally dinner. Snacks can make post- prandial assessment challenging. Look for hypoglycemic excursions: If you find hypoglycemia in the post-prandial periods, then look for a cause. Possible causes include: Too much insulin was given; Too little food was eaten for the amount of insulin; Food absorption was delayed; The insulin was timed or given at an inappropriate time; The measurement of the amount of insulin was incorrect; The type of bolus given was mismatched for the type of food eaten; for example, a normal bolus, rather than dual-wave, was provided for a pizza meal; Whether the patient had taken additional medication, which may result in an increased likelihood for hypoglycemia to occur; or The effect from prior exercise. Look for hyperglycemia: If hypoglycemia preceded the hyperglycemia, it needs to be corrected first before proceeding with subsequent evaluation. If hyperglycemia occurs (a peak above 18 post-meal), consider the following: The timing of insulin/bolus (e.g., despite the availability of rapid-acting insulin, insulin needs to be taken in advance of the meal); The type of bolus that was given, and the accuracy of the bolus; and The type of food. 2 AACE Medical Guidelines for Clinical Practice for the Management of Diabetes Mellitus. Endocrine Practice 13 (Suppl 1): 4-68, 7 1 PRACTICE GUIDE

12 3: AM 6: AM 9: AM 12: PM 3: PM 6: PM 9: PM REPORT INTERPRETATION KEY TAKEAWAYS: I. REPORT INTERPRETATION PROCESS FLOW The process flow outline below represent one method for organizing and evaluating the data. Sensor Summary Detail Quick Overview -Quality of data -Glucose excursion profile Pie Chart Red: Above Limits Green: Within Limits Blue: Below Limits Sensor Modal Day Identify clear patterns or lack of patterns across 24 hour period Glucose No Clear patterns? Yes Sensor Modal Time Identify specific patterns at meals or specific time -Review patterns 1 hr pre- & 3 hr post-meal or at customized time block Lunch 4 7 Sensor Daily Detail Identify cause & effect -Relate meals, insulin, exercise with glucose in each individual day -Reveal isolated excursion 4 7 1/28/9 (Wed) MEAL -1 hr +1 hr +2 hr +3 hr Refer to patient log sheet to support analysis with these reports PRACTICE GUIDE 11

13 II. KEY ITEMS TO LOOK FOR IN EACH OF THE SOLUTIONS SOFTWARE REPORTS 1. Identify hypoglycemia or hyperglycemia Identify the period patient s blood glucose is outside the target range. First, look for patterns of hypoglycemia anywhere anytime. Be sure you look at overnight, pre-prandial and post-prandial periods. Note: If hypoglycemia preceded the hyperglycemia, it needs to be corrected first. Then, look for hyperglycemia trends and patterns at overnight, pre-prandial, and post-prandial periods. 2. Identify a cause based on the identified pattern and correct it For each period, assess patient s activities (meals, medication, exercise) that preceded any excursions to identify potential cause and effect relationships. Consider the following when a certain pattern is identified from the reports: Pattern Nocturnal hypoglycemia Hypoglycemia Hyperglycemia Post-prandial glucose excursion (high or low) Hyperglycemia followed by hypoglycemia Hypoglycemia followed by hyperglycemia Potential Considerations Overnight basal Alcohol Evening exercise Mismatch of late evening snack and insulin delivered Type, quantity, timing and action of medication Reported symptoms Earlier exercise Mismatch of food eaten to insulin taken Basal insulin too high Difficulties in carbohydrate counting or assessing amounts of food Timing of insulin delivery and peak of insulin action related to food intake Over-treatment of hypoglycemia Compensation for fear of hypoglycemia Mismatch of type of bolus (Dual Wave ) for food Rebound hyperglycemia Dawn phenomenon (morning hyperglycemia) Type and quantity and action of medication Meal content high fat and protein meal versus delayed absorption. Timing and peak action of pre-meal medication History of gastroparesis Giving insulin after the meal Carbohydrate counting accuracy Mismatch of insulin with carbohydrates Timing of insulin bolus Correction factor assessment Insulin stacking (manual boluses) Use of Bolus Wizard Over treatment of hypoglycemia Rebound hyperglycemia Insulin stacking/ manual boluses SUMMARY Professional CGM reports provide valuable information in identifying potential cause and effect to help make better therapy decisions. The reports can address the following questions: Question: Are there problems, events, excursions? Answer: SENSOR MODAL DAY and MODAL TIME PERIODS REPORTS - Quick analysis of hypoglycemia and hyperglycemia (e.g., 24 Hour, Meal, Custom Time Views). Question: What is the cause of the problem or excursion? Answer: SENSOR DAILY DETAILS REPORT - Provides complete details of each day s control which may be related to various events during the day. Question: Are the medications and devices being utilized optimally? Answer: Utilize patient interview and pump reports to gain insight to BG monitoring, Bolus Wizard utilization, priming, site changing, use of the suspend feature, use of medication with meals, and so forth. 12 PRACTICE GUIDE

14 REPORT INTERPRETATION: Options Use the ipro CGM Progress Note (see Appendix form RI1) to document the findings. When interpreting the ipro CGM reports, use the ipro CGM patient log sheet and the patient s medical record as an information source. Noting the reason or indications for performing the ipro CGM evaluation/referral is important as it provides guidance or a focal point for interpretation. This is especially important for patients that are from a referring healthcare provider. It also provides documentation of rationale for performing the ipro CGM procedure. Perform interpretation with or without the patient present. Note that the service under CPT code is for the interpretation of the data and does not require a face-to-face meeting with the patient. Interpretations can be done in batches, (e.g., once a week), if that is more efficient for your practice. Alternatively, perform the interpretation just before meeting with the patient. Review ipro CGM reports with patients immediately after the data download or in a separate meeting. When you perform it depends on the other steps you have planned for the ipro CGM process, for example, your resources, office clinical flow, and patient scheduling. Review the reports on the computer screen or use a printed copy with patients. Consider handwriting notes on food intake, unusual food intake, or medical changes on the patient s printed report. Point out important events (such as hypoglycemic or hyperglycemic episodes) and their relationship to patient activities, and educate on the impact of meals, medication, and exercise on glucose levels. Provide the patient with a copy of the ipro CGM reports as an education tool. Visual reinforcement is one of the most effective benefits of an ipro CGM evaluation. Have them record recommendations on the report (learning tool). Enter patient activities from patient log sheets into Solutions Software to make it easier to interpret ipro CGM reports. THERAPY ADJUSTMENT: Options Therapy adjustments may be performed face-to-face, although some practices deliver them by telephone. It is still important to send or fax the patient a copy of the ipro CGM report and ipro CGM progress note detailing any therapy adjustments to be made, (e.g., a change in dosage, new medication, or how to correct highs and lows). This can be helpful when discussing the report over the phone with a patient. Therapy adjustments may be communicated to patients on the same day as the data download and interpretation, or on a separate visit such as during a routine visit. If appropriate, ask patients to see a diabetes educator after the visit. The physician and mid-level practitioner can interpret the data with the patient and recommend changes in dosage, new medication, diet, and/or lifestyle. Best Practice - Therapy Adjustments Consider making only one or two changes in a patient s therapy after each ipro CGM evaluation to properly understand cause and effect of therapy. Proactively address any questions patients may have while reviewing reports with them. Consider performing the ipro CGM evaluation (changing the patient's therapy) a few weeks prior to the routine visit. When he/she returns for the routine visit, the physician will be able to assess the effect of the recommendations and answer any questions the patients may have. PRACTICE GUIDE 13

15 REPORTING/ DOCUMENTATION: Complete the ipro CGM Progress Note, or document in medical record in usual manner. Confirm that the healthcare provider has signed the ipro CGM Progress Note, or document in medical record in usual manner. Include a copy of the ipro CGM Progress Note, Solutions Software Reports, and Patient Log Sheet to the patient s medical record. If applicable, fax or mail a copy to the referring healthcare provider. Confirm that the patient has been instructed on therapy changes. Provide the patient with instructions regarding therapy changes. ONGOING PATIENT ASSESSMENT Most practices follow up with the patient during the next office visit to see if the therapy adjustments are working. Practices may ask the patient to check BG values more frequently the week before the office visit to see how glucose values are, as well as perform A1C testing. In addition to the quarterly checkup, some offices have included these follow up options: Call the patient a week after the therapy adjustment to monitor the patient's progress. Ask the patient to return for a refresher course in diabetes management. Some offices ask the patient to return for a face-to-face with their healthcare provider after they have completed the classes. This visit is another opportunity to review the ipro CGM reports and changes in therapy with the patient. Repeat ipro CGM Evaluations A repeat CGM evaluation (as allowed by the insurance payor) is recommended to follow up on therapy adjustments and to continue to improve overall diabetes control. Some practices build a schedule into their routine care as to procedure frequency or follow-up study (e.g., repeat ipro CGM evaluation annually). Please check with insurance payors to understand specific guidelines for ipro CGM for CPT codes 9525 and Please refer to the Reimbursement section for further details on Professional CGM Coding and Coverage. The number of variations or visits depends on the patient s progression of care. Schedule follow up visits as needed. 14 PRACTICE GUIDE

16 APPENDIX REPORT INTERPRETATION SENSOR SUMMARY DETAIL REPORT The Sensor Summary Detail Report provides the healthcare provider with three key pieces of information: 1. Sensor blood glucose information: A full day of sensor wearing allows for up to 288 readings. On the first and last day, however, the report does not typically contain all 288 readings because they are not full days. Before you begin your interpretation, assess the tracings to make sure there is sufficient data. One of the key aspects of the report is tracking the standard deviation of the patient s glucose range. STDev is an abbreviation for standard deviation. It indicates how glucose sensor readings are spread over the glucose range. The lower the standard deviation, the lower the glycemic variability is. There are no absolute cutoff lines, but this gives the user a sense of the range of glucose variability. 2. Optimal accuracy criteria: This evaluates the relative accuracy of the sensor glucose data in relation to the reference Meter BG data. The criteria measurements provide an indication of the relative degree of accuracy and potential clinical reliability of the calibrated sensor data, compared with the entered Meter BG data. Medtronic uses three criteria to measure accuracy of data in Professional CGM: # of Paired Readings (Criteria: at least 3 Paired Readings per day) Mean Absolute Difference (MAD%) (Criteria: less than 28%) Correlation Coefficient (R) (Criteria: greater than or equals to.79) All must be met or the day will be labeled as X: Use Clinical Judgment Often times, the first day and the last day are deemed problematic for accuracy due to having not enough BG meter entries (e.g., less than 3 paired readings). Note: The software will not provide a correlation coefficient (R) if the meter BG values have a range of less than for that day. R will be labeled as N/A. If no correlation coefficient is given, the MAD also must be less than 18% to meet MDT s optimal accuracy criteria. 3. Glucose excursions: In target range In hypoglycemia range 29% 11% 6% In hyperglycemia range Example of an excursion pie chart Glucose excursion provides an overview of glycemic control and the amount of time per day spent in the target glucose range, in the high range, and in the low range. The BG target range set determines what the cutoffs are for hyperglycemia and hypoglycemia. Some set the range from 7 to 14, or 7 to 18 dl. The BG target range is set in the user preference for the practice, or can be individually set or changed before upload on the patient screen. Note: Certain patient populations (e.g., pediatric, pregnant, those with hypoglycemic unawareness) require a special target range. PRACTICE GUIDE 15

17 APPENDIX SENSOR SUMMARY DETAIL REPORT What do you do when the Sensor Summary Detail report reveals Use Clinical Judgment? 1. Understand the reasons, which are highlighted in blue in the report. Reason #1 (most common): less than 3 paired readings between fingersticks readings and sensors readings. This is quite common for the first day and last day since you do not have a full day. Reason #2: MAD% increase due to a large difference between sensor readings and BG readings. 2. Consider the following: If the blue box is on the first day and last day, use the report as normal. If MAD% is not far from the cutoff point, use them because they are still good for trend. If the patient does not perform fingersticks at least twice per day for most of the days, there may be insufficient data for analysis. In this case, the patient should consider repeating ipro CGM. If only one day is depicted with the Use Clinical Judgment, but the data on that day is consistent with the other days, then use it as normal. 16 PRACTICE GUIDE

18 APPENDIX REPORT INTERPRETATION SAMPLE REPORTS: Figure 7 provides examples of the Modal Day Summary report using the three-step methodology. FIGURE 7: Modal Day Summary report Dawn Phenomenon Friday Saturday Sunday Nocturnal Hypoglycemia 3: AM 6: AM 9: AM 12: PM 3: PM 6: PM 9: PM Nocturnal Hypoglycemia 14 6 Post-prandial Hyperglycemia 3: AM 6: AM 9: AM 12: PM 3: PM 6: PM 9: PM PRACTICE GUIDE 17

19 15 No Meal Markers Present REPORT INTERPRETATION APPENDIX SAMPLE REPORTS: Figure 8 demonstrates the importance of adding meal markers and events. FIGURE 8: Report with no meal markers Periods Breakfast 4 Lunch 4 Dinner 4 15 No Meal Markers Present 15 No Meal Markers Present hr Meal +1 hr +2 hr +3 hr -1 hr Meal +1 hr +2 hr +3 hr -1 hr Meal +1 hr +2 hr +3 hr Block A (6: - 5:59 AM) 4 Block B (6: AM - 11: PM) 4 Block C (6: PM - 6: AM) :am 2:pm 6:pm 1:pm 2:am 6:am 6:am 2:pm 6:pm 1:pm 2:am 6:am 6:am 2:pm 6:pm 1:pm 2:am 6:am FIGURE 8: Report with meal markers and events Periods Breakfast 4 Lunch 4 Dinner hr Meal +1 hr +2 hr +3 hr -1 hr Meal +1 hr +2 hr +3 hr -1 hr Meal +1 hr +2 hr +3 hr Block A (6: - 5:59 AM) 4 Block B (6: AM - 11: PM) 4 Block C (6: PM - 6: AM) :am 2:am 3:am 4:am 5:am 6:am 6:am 1:am 2:pm 6:pm 1:pm 6:pm 1:pm 12:am 2:am 4:am 6:am 18 PRACTICE GUIDE

20 APPENDIX - FORMS REPORT INTERPRETATION (Form RI1 page 1 of 2)

21 APPENDIX - FORMS REPORT INTERPRETATION (Form RI1 page 2 of 2)

CareLink. software REPORT REFERENCE GUIDE. Management Software for Diabetes

CareLink. software REPORT REFERENCE GUIDE. Management Software for Diabetes CareLink Management Software for Diabetes software REPORT REFERENCE GUIDE How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used

More information

Report Reference Guide

Report Reference Guide Report Reference Guide How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used to generate the sample reports was from sample patient

More information

Report Reference Guide. THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1

Report Reference Guide. THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1 Report Reference Guide THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1 How to use this guide Each type of CareLink report and its components are described in the following sections.

More information

Welcome to CareLink Pro

Welcome to CareLink Pro Reference Guide Welcome to CareLink Pro This guide was developed to serve as a reference for obtaining patient data and reviewing CareLink Pro reports. Getting Started with CareLink Pro Adding New Patients

More information

Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond)

Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond) Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond) 9501366-011 20110401 Objectives Understand the need for insulin pumps and CGMS in managing

More information

THERAPY MANAGEMENT SOFTWARE FOR DIABETES

THERAPY MANAGEMENT SOFTWARE FOR DIABETES THERAPY MANAGEMENT SOFTWARE FOR DIABETES Report Report Interpretation Reference Guide Guide 2009 Medtronic MiniMed. All rights reserved. 6025274-012_a CareLink Pro Report Reference Guide 0 p.2 Adherence

More information

THERAPY MANAGEMENT SOFTWARE FOR DIABETES

THERAPY MANAGEMENT SOFTWARE FOR DIABETES THERAPY MANAGEMENT SOFTWARE FOR DIABETES Report Report Interpretation Reference Guide Guide 2007 Medtronic MiniMed. All rights reserved. 6025274-0U2 120707 CareLink Pro Report Reference Guide 0 p.2 Sensor

More information

OneTouch Reveal web app Report Reference Guide

OneTouch Reveal web app Report Reference Guide OneTouch Reveal web app Report Reference Guide Your step-by-step guide to setting up and using the OneTouch Reveal web app OneTouch Verio meter OneTouch Verio Flex meter OneTouch Verio IQ meter OneTouch

More information

Fine-tuning of The Dose of Insulin Pump

Fine-tuning of The Dose of Insulin Pump Fine-tuning of The Dose of Insulin Pump The manual does not guarantee specific individual or specific applicability of the environment, there is no express or implied warranties. Contents of this manual

More information

CARELINK PERSONAL ACTIONABLE INSIGHTS FOR BETTER DIABETES MANAGEMENT CARELINK REPORTS GUIDE

CARELINK PERSONAL ACTIONABLE INSIGHTS FOR BETTER DIABETES MANAGEMENT CARELINK REPORTS GUIDE CARELINK PERSONAL ACTIONABLE INSIGHTS FOR BETTER DIABETES MANAGEMENT CARELINK REPORTS GUIDE CARELINK PERSONAL ACTIONABLE INSIGHTS FOR BETTER DIABETES MANAGEMENT As part of your diabetes therapy you have

More information

GLOOKO REPORT REFERENCE GUIDE

GLOOKO REPORT REFERENCE GUIDE GLOOKO REPORT REFERENCE GUIDE November 2018 Version IFU-0010 02 Contents Intended Use... 2 Warnings... 2 Introduction... 3 Reports... 4 Report Criteria...4 Date Range... 4 Glucose Data Source... 4 Exercise

More information

Calgary Diabetes Centre Insulin Pump Therapy: Preparation and Expectations

Calgary Diabetes Centre Insulin Pump Therapy: Preparation and Expectations Calgary Diabetes Centre Insulin Pump Therapy: Preparation and Expectations This is a long and important document. It lists the steps for starting insulin pump therapy at the Calgary Diabetes Centre. It

More information

PROTOCOL FOR HYBRID CLOSED LOOP TECHNOLOGY

PROTOCOL FOR HYBRID CLOSED LOOP TECHNOLOGY PROTOCOL FOR HYBRID CLOSED LOOP TECHNOLOGY Situations Requiring Special Consideration and Resource Documents Second Edition MiniMed 67G System Medical Education TABLE OF CONTENTS A PROTOCOL FOR HYBRID

More information

RELEASED. first steps. Icon Icon name What it means

RELEASED. first steps. Icon Icon name What it means Icon Icon name What it means Connection The connection icon appears green when the Sensor feature is on and your transmitter is successfully communicating with your pump. The connection icon appears gray

More information

Aviva Combo BLOOD GLUCOSE METER. Advanced Owner s Booklet for Self-Testing Only

Aviva Combo BLOOD GLUCOSE METER. Advanced Owner s Booklet for Self-Testing Only Aviva Combo BLOOD GLUCOSE METER Advanced Owner s Booklet for Self-Testing Only Before You Start Testing About the meter and test strips Carefully read and follow the instructions in the Getting Started

More information

Current Glucometers. Junior s s Glucose Log. All have advantages and disadvantages Answer 2

Current Glucometers. Junior s s Glucose Log. All have advantages and disadvantages Answer 2 Diabetes Dilemmas: Using Technology To Solve Clinical Conundrums Stephen E. Gitelman, MD UCSF A teenager with type 1 diabetes for 5 years comes into your office for a follow- up visit. You want to review

More information

Continuous Glucose Monitoring

Continuous Glucose Monitoring Continuous Glucose Monitoring What is Continuous Glucose Monitoring? Blood glucose meters measure glucose in your blood and glucose sensors measure glucose levels in the fluid around the cells They are

More information

Understanding the CareLinkTM Sensor Meter Overview Report: Page 1

Understanding the CareLinkTM Sensor Meter Overview Report: Page 1 Understanding the CareLinkTM Sensor Meter Overview Report: Page 1 Sensor & Meter Overview (1 of 3) 4-Hour Glucose Sensor Overlay - Readings & Averages (mg/dl) 1 Glucose Sensor Overlay Bedtime to Wake-Up

More information

Interpreting the charts & graphs

Interpreting the charts & graphs Report reference guide mg/dl The diasend solution Interpreting the charts & graphs diasend is a universal cloud-based diabetes data management system, that enables you to upload data from meters, pumps

More information

Introducing DEXCOM STUDIO INTUITIVE. FOCUSED. SIMPLIFIED. HELP TAKE the GUESSWORK OUT of GLUCOSE PATTERN MANAGEMENT

Introducing DEXCOM STUDIO INTUITIVE. FOCUSED. SIMPLIFIED. HELP TAKE the GUESSWORK OUT of GLUCOSE PATTERN MANAGEMENT DEXCOM STUDIO Introducing Continuous Glucose Monitoring Software INTUITIVE. FOCUSED. SIMPLIFIED. HELP TAKE the GUESSWORK OUT of GLUCOSE PATTERN MANAGEMENT GLUCOSE PATTERN MANAGEMENT Pre and Post Prandial

More information

USING THE MINIMED 670G SYSTEM

USING THE MINIMED 670G SYSTEM USING THE MINIMED 670G SYSTEM Instructions for the Experienced MiniMed 630G System User USING THE MINIMED 670G SYSTEM: INSTRUCTIONS FOR THE EXPERIENCED USER Checklist for starting on your MiniMed 670G

More information

Blood glucose Meter Roche USA V6/ PMS 287 Proof Print Number 209 Advanced Owner s Booklet

Blood glucose Meter Roche USA V6/ PMS 287 Proof Print Number 209 Advanced Owner s Booklet This file may not print or view at 100%. Die lines and color breaks do not print. Roche USA 50841 V6/1 06434258002 Black Proof Print Number 209 06434258002-0512 Roche USA 50841 V6/2 06434258002 Cyan Proof

More information

BREAKDOWN OF THE CARELINK REPORTS GETTING STARTED WITH CARELINK PERSONAL SOFTWARE

BREAKDOWN OF THE CARELINK REPORTS GETTING STARTED WITH CARELINK PERSONAL SOFTWARE BREAKDOWN OF THE CARELINK REPORTS GETTING STARTED WITH CARELINK PERSONAL SOFTWARE TABLE OF CONTENTS GETTING STARTED WITH CARELINK PERSONAL SOFTWARE Introducing CareLink Personal Software Before You Start...

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Calgary Diabetes Centre Insulin Pump Therapy: Preparation and Expectations

Calgary Diabetes Centre Insulin Pump Therapy: Preparation and Expectations Calgary Diabetes Centre Insulin Pump Therapy: Preparation and Expectations This is a long and important document. It lists the steps for starting insulin pump therapy at the Calgary Diabetes Centre. It

More information

Understanding the CareLink TM Therapy Management Dashboard Report

Understanding the CareLink TM Therapy Management Dashboard Report 3 2 1 5 6 7 4 1 This is a great place to start recognizing trends. In this example you may see plenty of events that result in a low glucose trend. A low glucose is identified as a value less than 70mg/dL.

More information

Getting Started. Learning Guide. with Insulin Pump Therapy. PUMP Foundations. for the MiniMed 530G with Enlite

Getting Started. Learning Guide. with Insulin Pump Therapy. PUMP Foundations. for the MiniMed 530G with Enlite Getting Started with Insulin Pump Therapy for the MiniMed 530G with Enlite Learning Guide PUMP Foundations MiniMed 530G Insulin Pump Settings Form: We recommend that you record all settings on this form

More information

USING THE MINIMED 670G SYSTEM. Instructions for the Experienced MiniMed 630G System User

USING THE MINIMED 670G SYSTEM. Instructions for the Experienced MiniMed 630G System User USING THE MINIMED 670G SYSTEM Instructions for the Experienced MiniMed 630G System User This is a supplemental guide. For complete instructions and safety information, please see your MiniMed 670G System

More information

Professional CGM Reimbursement Guide

Professional CGM Reimbursement Guide Professional CGM Reimbursement Guide 2015 TABLE OF CONTENTS Coding, Coverage and Payment...2 Coding and Billing...2 CPT Code 95250...3 CPT Code 95251...3 Incident to Billing for Physicians..............................................

More information

RELEASED. Clearing your active insulin

RELEASED. Clearing your active insulin To clear all your settings: 1. Make sure the pump is not connected to your body. 2. Go to the Manage Settings screen. Menu > Utilities > Manage Settings 3. Simultaneously press and hold and until the Manage

More information

Diabetes and Technology. Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE

Diabetes and Technology. Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE Diabetes and Technology Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE Disclosure Speaker s Bureau: Janssan Pharmaceuticals Current Technology V-Go by Valeritas Continuous Sensors (personal

More information

Diabetes Management App. Instruction Manual

Diabetes Management App. Instruction Manual Diabetes Management App Instruction Manual Accu-Chek Connect Diabetes Management App Overview The Accu-Chek Connect diabetes management app (hereafter referred to as the app) is designed to help you: Transfer

More information

UNDERSTANDING THE BASIC FEATURES AND MANAGEMENT IN THE SCHOOL SETTING CHRISTINE HERTLER RN BSN CDE & MARY MCCARTHY RN CDE

UNDERSTANDING THE BASIC FEATURES AND MANAGEMENT IN THE SCHOOL SETTING CHRISTINE HERTLER RN BSN CDE & MARY MCCARTHY RN CDE UNDERSTANDING THE BASIC FEATURES AND MANAGEMENT IN THE SCHOOL SETTING CHRISTINE HERTLER RN BSN CDE & MARY MCCARTHY RN CDE The insulin pump Replaces injections Delivers insulin through a soft cannula

More information

1. Continuous Glucose Monitoring

1. Continuous Glucose Monitoring 1. Continuous Glucose Monitoring 1. Physiology of interstitial fluid glucose 2. Comparison of CGM and self-monitored blood glucose (SMBG) data 3. Insulin dosing indication in BGM vs. CGM & the FDA 4. Protection

More information

Optimizing Therapy and Clinical Outcomes Using Real-Time Continuous Glucose Monitoring (AADE PRODUCT THEATRE) August 7, 2014 Orlando, FL

Optimizing Therapy and Clinical Outcomes Using Real-Time Continuous Glucose Monitoring (AADE PRODUCT THEATRE) August 7, 2014 Orlando, FL Optimizing Therapy and Clinical Outcomes Using Real-Time Continuous Glucose Monitoring (AADE PRODUCT THEATRE) August 7, 2014 Orlando, FL Welcome and Introduction Orlando, FL August 7 th, 2014 Keri Weindel,

More information

Real-Time Continuous Glucose Monitoring: From Application to Evaluation

Real-Time Continuous Glucose Monitoring: From Application to Evaluation Real-Time Continuous Glucose Monitoring: From Application to Evaluation Gary Scheiner MS, CDE Owner/Director, Integrated Diabetes Services 333 E. Lancaster Ave., Suite 24 Wynnewood, PA 1996 (877) 735-3648

More information

Live life, less complicated. InPen MOBILE APP. Healthcare Provider INSTRUCTIONS FOR USE. CompanionMedical.com

Live life, less complicated. InPen MOBILE APP. Healthcare Provider INSTRUCTIONS FOR USE. CompanionMedical.com InPen MOBILE APP Healthcare Provider INSTRUCTIONS FOR USE TABLE OF CONTENTS Introduction...3 InPen Mobile App...3 Intended Use...3 Indications for Use...3 Contraindications...3 Start Orders...4 General

More information

Quick Reference Guide

Quick Reference Guide FLASH GLUCOSE MONITORING SYSTEM Quick Reference Guide IMPORTANT USER INFORMATION Before you use your System, review all the product instructions and the Interactive Tutorial. The Quick Reference Guide

More information

POPULATION TRACKER - DREAMED USER GUIDE

POPULATION TRACKER - DREAMED USER GUIDE POPULATION TRACKER - DREAMED USER GUIDE November 2018 IFU-0011 05 TABLE OF CONTENTS TABLE OF CONTENTS GENERAL INFORMATION... 1 Product Description... 1 Glooko Intended Use... 1 DreaMed Intended Use...

More information

Making the Most of Continuous Glucose Monitoring

Making the Most of Continuous Glucose Monitoring Making the Most of Continuous Glucose Monitoring Gary Scheiner MS, CDE Owner & Clinical Director Integrated Diabetes Services LLC Wynnewood, PA AADE 2014 Diabetes Educator of the Year gary@integrateddiabetes.com

More information

Technology for Diabetes: 101 Basic Rules of the Road. Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE

Technology for Diabetes: 101 Basic Rules of the Road. Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE Technology for Diabetes: 101 Basic Rules of the Road Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE Quick Pump Facts! o Constant insulin supply o Pager-sized mini-computer worn

More information

Quick Reference Guide

Quick Reference Guide FLASH GLUCOSE MONITORING SYSTEM Quick Reference Guide IMPORTANT USER INFORMATION Before you use your System, review all the product instructions and the Interactive Tutorial. The Quick Reference Guide

More information

Insulin Pumps and Continuous Glucose Sensors- Embracing Technology. Susan Cavalier, BS, RN, CDE Manager, Diabetes Educator Sanford Diabetes Education

Insulin Pumps and Continuous Glucose Sensors- Embracing Technology. Susan Cavalier, BS, RN, CDE Manager, Diabetes Educator Sanford Diabetes Education Insulin Pumps and Continuous Glucose Sensors- Embracing Technology Susan Cavalier, BS, RN, CDE Manager, Diabetes Educator Sanford Diabetes Education Diabetes Management Tools in 1974 Insulin pump history

More information

CGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER

CGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER CGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER Case 1: CGM use during pregnancy 29 yo G1P0000 at 10 5/7 weeks gestation presents to set

More information

OneTouch Reveal Web Application. User Manual for Healthcare Professionals Instructions for Use

OneTouch Reveal Web Application. User Manual for Healthcare Professionals Instructions for Use OneTouch Reveal Web Application User Manual for Healthcare Professionals Instructions for Use Contents 2 Contents Chapter 1: Introduction...4 Product Overview...4 Intended Use...4 System Requirements...

More information

THE MINIMED 670G SYSTEM SCHOOL NURSE GUIDE

THE MINIMED 670G SYSTEM SCHOOL NURSE GUIDE THE MINIMED 670G SYSTEM SCHOOL NURSE GUIDE Indicated for type 1 patients 14 and over. Prescription required. WARNING: Medtronic performed an evaluation of the MiniMed 670G system and determined that it

More information

Continuous Glucose Monitoring System

Continuous Glucose Monitoring System Continuous Glucose Monitoring System Policy Number: Original Effective Date: MM.02.003 03/13/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/2017 Section: DME Place(s)

More information

Date of birth: Type 2 Other: Parent/guardian 1: Address: Telephone: Home: Work: Cell: address: Camper physician / health care provider:

Date of birth: Type 2 Other: Parent/guardian 1: Address: Telephone: Home: Work: Cell:  address: Camper physician / health care provider: Day & Evening Camp 2018 Specialized Health Care Diabetes Medical Management Plan Must be completed if your camper has diabetes. Parent/guardian and physician signature required. **We will also accept copies

More information

V-Go : Simple to start, easy to use

V-Go : Simple to start, easy to use V-Go : Simple to start, easy to use Patient Start Guide Make multiple daily insulin shots a thing of the past. Take control with V-Go. V-Go Customer Care personalized 1-on-1 support for you Call 1-866-881-1209

More information

Diabetes Medical Management Plan (DMMP)

Diabetes Medical Management Plan (DMMP) Diabetes Medical Management Plan (DMMP) Page 1 of 7, DMMP This plan should be completed by the student s personal diabetes health care team, including the parents/guardians. It should be reviewed with

More information

Diabetes Devices Workshop Angela Aldrich, PharmD, PhC April Mott, PharmD, PhC, BCPS Presbyterian Medical Group 28 January 2018

Diabetes Devices Workshop Angela Aldrich, PharmD, PhC April Mott, PharmD, PhC, BCPS Presbyterian Medical Group 28 January 2018 Diabetes Devices Workshop Angela Aldrich, PharmD, PhC April Mott, PharmD, PhC, BCPS Presbyterian Medical Group 28 January 2018 Pumps & Sensors & Meters, Oh My! A Tale of Two Meters Technology for glucometers

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Diabetes Medical Management Plan (DMMP)

Diabetes Medical Management Plan (DMMP) Diabetes Medical Management Plan (DMMP) This plan should be completed by the student s personal diabetes health care team, including the parents/guardians. It should be reviewed with relevant school staff

More information

Advances in Diabetes Care Technologies

Advances in Diabetes Care Technologies 1979 Advances in Diabetes Care Technologies 2015 Introduction Insulin pump use: ~ 20% - 30% of patients with T1DM < 1% of insulin-treated patients with T2DM 2007 FDA estimates ~375,000 insulin pumps for

More information

Continuous Glucose Monitoring System

Continuous Glucose Monitoring System Continuous Glucose Monitoring System Policy Number: Original Effective Date: MM.02.003 03/13/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 4/1/2018 Section: DME Place(s)

More information

Case Study. Patient Profile. Baseline Report - Daily Patterns. Insights

Case Study. Patient Profile. Baseline Report - Daily Patterns. Insights Case Study Patient Profile Sex/Age: Male, elderly Disease diagnosis: Type 2 for the past 30 years, recurrent episodes of hunger HbA1c: 6.2% Diabetes medication profile: DPP-4 inhibitor 50 mg twice a day,

More information

NEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP

NEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP NEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP No commercial support or sponsorship was received for this project I have nothing to disclose OBJECTIVES Identify at

More information

Pump Basics for the School Nurse. Children's Endocrinology Center of Dallas

Pump Basics for the School Nurse. Children's Endocrinology Center of Dallas Pump Basics for the School Nurse Children's Endocrinology Center of Dallas Pump Basics Covers: A general overview of the insulin pump Refer to the manufacturer s website for the specific features of each

More information

The Realities of Technology in Type 1 Diabetes

The Realities of Technology in Type 1 Diabetes The Realities of Technology in Type 1 Diabetes May 6, 2017 Rosanna Fiallo-scharer, MD Margaret Frederick, RN Disclosures I have no conflicts of interest to disclose I will discuss some unapproved treatments

More information

Self-Monitoring Blood Glucose (SMBG) Frequency & Pattern Tool

Self-Monitoring Blood Glucose (SMBG) Frequency & Pattern Tool Self-Monitoring Blood Glucose () Pattern Recommendation: Basal Insulin Only (To Target) NPH or long-acting analogue, typically given at. at least as often as is being given. Optional, less frequent can

More information

Quick Reference Guide

Quick Reference Guide FLASH GLUCOSE MONITORING SYSTEM Quick Reference Guide FreeStyle LibreLink app A FreeStyle Libre product IMPORTANT USER INFORMATION Before you use your System, review all the product instructions and the

More information

State of California Health and Human Services Agency Department of Health Care Services

State of California Health and Human Services Agency Department of Health Care Services State of California Health and Human Services Agency Department of Health Care Services JENNIFER KENT Director EDMOND G. BROWN JR Governor DATE: N.L.: 03-0317 Index: Benefits TO: ALL COUNTY CALIFORNIA

More information

Continuous Glucose Monitoring System

Continuous Glucose Monitoring System Continuous Glucose Monitoring System Policy Number: Original Effective Date: MM.02.003 03/13/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/2016 Section: DME Place(s)

More information

PATIENT TRAINING CHECKLIST MINIMED 670G SYSTEM

PATIENT TRAINING CHECKLIST MINIMED 670G SYSTEM Technical Training Insulin Pump Infusion Set: Insulin Pump Model: BASIC FEATURES Patient has demonstrated understanding of: Button Functions Home Screen Menu review Status Screens Battery type/insertion

More information

Pumps & Sensors made easy. OPADA ALZOHAILI MD FACE Endocrinology Assistant Professor Wayne State University

Pumps & Sensors made easy. OPADA ALZOHAILI MD FACE Endocrinology Assistant Professor Wayne State University Pumps & Sensors made easy OPADA ALZOHAILI MD FACE Endocrinology Assistant Professor Wayne State University DeFronzo RA. Diabetes. 2009;58:773-795. Ominous Octet Relationship of b-cell Dysfunction and Development

More information

Case Study. Patient Profile. Baseline Report - Daily Patterns. Insights

Case Study. Patient Profile. Baseline Report - Daily Patterns. Insights Case Study Patient Profile Sex/Age: Female, 48 years old Disease diagnosis: Type 2 for past 13 years, coronary artery disease for 3 years, complains of severe tiredness HbA1c: 9.0% Diabetes medication

More information

Insulin Pump Therapy. WakeMed Children s Endocrinology & Diabetes WakeMed Health & Hospitals Version 1.3, rev 5/21/13 MP

Insulin Pump Therapy. WakeMed Children s Endocrinology & Diabetes WakeMed Health & Hospitals Version 1.3, rev 5/21/13 MP Insulin Pump Therapy WakeMed Children s Endocrinology & Diabetes Overview What is an insulin pump? What are the advantages and disadvantages of an insulin pump? Lifestyle Changes Food Management Exercise

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Continuous Monitoring of Glucose in the Interstitial Fluid File Name: Origination: Last CAP Review: Next CAP Review: Last Review: continuous_monitoring_of_glucose_in_the_interstitial_fluid

More information

Medical Education. Personal Continuous Glucose Monitoring Protocol. Innovating for life.

Medical Education. Personal Continuous Glucose Monitoring Protocol. Innovating for life. Personal Continuous Glucose Monitoring Protocol A Guide to Continuous Glucose Monitoring Integrated with Insulin Pump Therapy Includes Alert and Trend Management as well as Threshold Medical Education

More information

Making Sense of Glucose Monitoring. My Journey with Glucose Monitoring Over the Last 37 Years 8/7/2017

Making Sense of Glucose Monitoring. My Journey with Glucose Monitoring Over the Last 37 Years 8/7/2017 HSW1 Disclosure to Participants Making Sense of Glucose Monitoring Alison B. Evert, MS, RD, CDE UW Neighborhood Clinics UW Medicine Seattle, WA Conflict of Interest (COI) and Financial Relationship Disclosures:

More information

Continuous Glucose Monitors for Diabetes Management

Continuous Glucose Monitors for Diabetes Management Continuous Glucose Monitors for Diabetes Management Ryan Huang, DO PGY II, Sonia Garcia-Jayne, DO PGY II Mandeep Gill, DO PGY I, Justin Leeka, DO, PGY I, Catherine Nguyen OMS IV Family Medicine Residency,

More information

Virginia Diabetes Medical Management Plan (DMMP)

Virginia Diabetes Medical Management Plan (DMMP) Virginia Diabetes Medical Management Plan (DMMP) Adapted from the National Diabetes Education Program DMMP (2016) This plan should be completed by the student s personal diabetes health care team, including

More information

Clinical Value and Evidence of Continuous Glucose Monitoring

Clinical Value and Evidence of Continuous Glucose Monitoring Clinical Value and Evidence of Continuous Glucose Monitoring 9402313-012 Objective To review the clinical value and the recent clinical evidence for Professional and Personal CGM Key Points CGM reveals

More information

First steps for success.

First steps for success. First steps for success. Getting to know continuous glucose monitoring (CGM). The Animas Vibe System is approved for persons age 2 and older. Important Safety Information The Animas Vibe Insulin Pump and

More information

Using the Bolus Wizard Calculator

Using the Bolus Wizard Calculator 9501179-011 Using the Bolus Wizard Calculator Objective Describe the features and benefits of the Bolus Wizard Calculator Key Points The Bolus Wizard: Estimates high blood glucose corrections using the

More information

Artificial Pancreas Device System (APDS)

Artificial Pancreas Device System (APDS) Medical Policy Manual Durable Medical Equipment, Policy No. 77 Artificial Pancreas Device System (APDS) Next Review: October 2019 Last Review: October 2018 Effective: November 1, 2018 IMPORTANT REMINDER

More information

Incorporating CGM Into Clinical Decision Making. Etie Moghissi, MD, FACE Clinical Associate Professor, David Geffen School of Medicine UCLA

Incorporating CGM Into Clinical Decision Making. Etie Moghissi, MD, FACE Clinical Associate Professor, David Geffen School of Medicine UCLA Incorporating CGM Into Clinical Decision Making Etie Moghissi, MD, FACE Clinical Associate Professor, David Geffen School of Medicine UCLA 1 Limitations of Current Glucose Monitoring Methods A1c Standard

More information

The LibreView system gives you a consistent set of clear, intuitive reports that make it easier and faster to discover patterns and trends.

The LibreView system gives you a consistent set of clear, intuitive reports that make it easier and faster to discover patterns and trends. Report Overview The LibreView system gives you a consistent set of clear, intuitive reports that make it easier and faster to discover patterns and trends. Not all meters and meter reports are available

More information

DISCOVER THE POWER OF CONNECTION MINIMED 640G

DISCOVER THE POWER OF CONNECTION MINIMED 640G DISCOVER THE POWER OF CONNECTION MINIMED 640G INSULIN PUMP THERAPY CHANGING LIVES TODAY Has your child just been diagnosed with insulin dependent diabetes? Or perhaps they ve been on multiple daily injection

More information

Pumping Insulin is it for your patients?

Pumping Insulin is it for your patients? Pumping Insulin is it for your patients? YOU CAN make managing diabetes easier. Fred Porcase D.O. Disclosures to Participants Conflicts Of Interest and Financial Relationships Disclosures: No professional

More information

Supplemental Health Record and Authorization for Care of Child with Insulin Dependent Diabetes

Supplemental Health Record and Authorization for Care of Child with Insulin Dependent Diabetes 477 Beaverkill Road Olivebridge, New York 12461 (845) 657-8333 Ext. 15 Fax (845) 657-8489 martin.bernstein@ashokancenter.org www.ashokancenter.org 2012-13 Supplemental Health Record and Authorization for

More information

Understanding the Assessment and Progress Report

Understanding the Assessment and Progress Report Understanding the ssessment and Progress Report ssessment and Progress 8//2-8/7/2 (7 Days) 3 7/2/2-7/27/2 (7 Days) 4 25-75% -% verage 2 4: M- 5:4 M Hyperglycemic patterns() :45 PM- :3 PM 2 3 :2 M- :5 M

More information

Guide to Starting and Adjusting Insulin for Type 2 Diabetes*

Guide to Starting and Adjusting Insulin for Type 2 Diabetes* Guide to Starting and Adjusting Insulin for Type 2 Diabetes* www.cadth.ca * Adapted from Guide to Starting and Adjusting Insulin for Type 2 Diabetes, 2008 International Diabetes Center, Minneapolis, MN.

More information

Diabetes Medical Management Plan (DMMP) Adapted from Helping the Student with Diabetes Succeed: A Guide for School Personnel (2016)

Diabetes Medical Management Plan (DMMP) Adapted from Helping the Student with Diabetes Succeed: A Guide for School Personnel (2016) Diabetes Medical Management Plan (DMMP) Adapted from Helping the Student with Diabetes Succeed: A Guide for School Personnel (2016) This plan should be completed by the student's personal diabetes health

More information

Your pet s diabetes is manageable

Your pet s diabetes is manageable BLOOD GLUCOSE MONITORING SYSTEM Your pet s diabetes is manageable Treatment and Monitoring Plan for: Pet s Name: Clinic Name: Primary Vet: Clinic Phone No.: Clinic Email: Emergency Phone No: Today s Date:

More information

Interpretation and management of fasting hyperglycaemia in adults with Type 1 diabetes using MDI insulin regimen

Interpretation and management of fasting hyperglycaemia in adults with Type 1 diabetes using MDI insulin regimen Interpretation and management of fasting hyperglycaemia in adults with Type 1 diabetes using MDI insulin regimen For many years it was believed that high blood glucose (BG) levels first thing in the morning

More information

For Safe and Effective Diabetes Management

For Safe and Effective Diabetes Management For Safe and Effective Diabetes Management How FreeStyle Libre Works FreeStyle Libre is a system for continuous glucose monitoring (CGM) that gives you easy access to your glucose numbers. CGM has been

More information

DIABETES MANAGEMENT PLAN 2017

DIABETES MANAGEMENT PLAN 2017 EARLY CHILDHOOD EDUCATION AND CARE SETTING Insulin pump therapy Use in conjunction with Action Plan DIABETES MANAGEMENT PLAN 2017 Name of child: Name of centre: of birth: Age: This plan should be reviewed

More information

Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical

Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical Practice Guideline Task Force Members Anne Peters, MD (Chair)

More information

MINIMED 640G WITH SMARTGUARD GIVES YOU CONFIDENCE TO TAKE CONTROL OF YOUR DIABETES

MINIMED 640G WITH SMARTGUARD GIVES YOU CONFIDENCE TO TAKE CONTROL OF YOUR DIABETES MINIMED 640G WITH SMARTGUARD GIVES YOU CONFIDENCE OF YOUR DIABETES HAVE YOU CONSIDERED THE REAL IMPACT HYPOS HAVE ON YOUR LIFE? AN ESTIMATED 1 HOUR EVERY DAY IS LOST TO THE MANAGEMENT OF 43% OF PEOPLE

More information

Table of Contents. Contour Diabetes App User Guide

Table of Contents. Contour Diabetes App User Guide Table of Contents Introduction... 3 About the CONTOUR Diabetes App... 3 System and Device Requirements... 3 Intended Use... 3 Getting Started... 3 Downloading CONTOUR... 3 Apple... 3 Android... 4 Quick

More information

Advances in Diabetes Care Technologies

Advances in Diabetes Care Technologies 1979 Advances in Diabetes Care Technologies 2015 Introduction Roughly 20% - 30% of patients with T1DM and fewer than 1% of insulin-treated patients with T2DM use an insulin pump In 2007, the US FDA estimated

More information

Do fat and protein affect post prandial glycemia in the outpatient real world setting? Neha Verma, MD Robert Melfi, MD

Do fat and protein affect post prandial glycemia in the outpatient real world setting? Neha Verma, MD Robert Melfi, MD Do fat and protein affect post prandial glycemia in the outpatient real world setting? Neha Verma, MD Robert Melfi, MD Objectives Understand the effect of fat and protein on glycemic excursion in the post-prandial

More information

Keeping your diabetes support as mobile as you are,

Keeping your diabetes support as mobile as you are, Millions of people have diabetes. But we at Novo Nordisk know that managing diabetes is a personal journey. That is why we created the e-book Your guide to better office visits, with valuable insights

More information

Report reference guide. mmol/l. One. solution EMR. No fuss

Report reference guide. mmol/l. One. solution EMR. No fuss Report reference guide mmol/l One solution No fuss 0000000000 00 0 0000 00 0 0 0 0 0 0 000000000 0 0 00 0 0 0 00 00 0 0 0 0 0 0 00 00000000000000000000 00 EMR About diasend. Plug Transmitter into your

More information

WOULD YOU LIKE TO REDUCE THE FEAR OF HYPOGLYCAEMIA FOR YOUR PATIENTS?

WOULD YOU LIKE TO REDUCE THE FEAR OF HYPOGLYCAEMIA FOR YOUR PATIENTS? WOULD YOU LIKE TO REDUCE THE FEAR OF HYPOGLYCAEMIA FOR YOUR PATIENTS? THE ONLY SYSTEM CLINICALLY PROVEN TO REDUCE HYPOGLYCAEMIA MINIMED 640G SYSTEM WITH SMARTGUARD TECHNOLOGY 1 HYPOGLYCAEMIA IS CHALLENGING

More information

CGM: Continuous Glucose Monitoring Making Sense of It All AW: ANCO/GEND/1016/0117

CGM: Continuous Glucose Monitoring Making Sense of It All AW: ANCO/GEND/1016/0117 CGM: Continuous Glucose Monitoring Making Sense of It All Objectives Review how to do a time effective interpretation of CGM and insulin pump download data Review how medications, lifestyle, and current

More information

Tools for Life Introduction to patterns

Tools for Life Introduction to patterns Tools for Life Introduction to patterns Insulin Food Activity Tools for Life. Questions? 1-800-227-8862 OneTouch.com 2011 LifeScan, Inc. Milpitas, CA 95035 11/11 AW 3085039B 3 YOU + Congratulations for

More information

Diabetes Medical Management Plan (DMMP)

Diabetes Medical Management Plan (DMMP) Diabetes Medical Management Plan (DMMP) This plan should be completed by the student s personal diabetes health care team, including the parents/guardian. It should be reviewed with relevant school staff

More information